|Day Low/High||22.27 / 23.60|
|52 Wk Low/High||19.44 / 42.91|
Jim Cramer is bullish on Alaska Air Group, Corcept Therapeutics, First Solar and more.
Jim Cramer says people care about natural disasters, but the markets are moved by data points, such as Apple's iPhone news.
Trump has both good news and bad news for the market, while Yellen has no news. In the portfolio, we add to 3 positions and upgrade another.
Jim Cramer is bullish on Novartis AG, Sirius XM Radio, Coupa Software and Juno Therapeutics.
Jim Cramer says the calendar and the momentum holders are coalescing to produce selling. Here's what investors should do about it.
A look at three discipline names to consider as oil begins to turn around.
Markets see volatility as geopolitical tensions rise. We closed out one tech position and initiated another.
It's lost some 30% since Cramer bought it for his charitable trust.
The stock has lost some 30% since Cramer bought it for his charitable trust.
The most recent short interest data was recently released for the 07/14/2017 settlement date, and Apache Corp is the #55 most shorted of the S&P 500 components, based on 8.87 "days to cover." There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then divided by the average daily volume, to express the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
We're hung on Apache and Cimarex, Cramer laments.
TJX and financials are trading well this morning, and some oil stocks are getting a reprieve from last week's declines.
Callout: Results and guidance lift markets, dodging D.C. drama.
Strong earnings and guidance lift markets. We drop a couple of names from the portfolio.
The oil producer recently had looked attractive fundamentally and technically, but now is projecting a downside move.
Here are some top picks from our key strategist for August.
Wherever a dart lands next is an even better short than the last toss.
Benno Dorer, chairman and CEO of Clorox, tells Jim Cramer he sees opportunity in the Renew Life brand.
Steve Holmes, chairman and CEO of Wyndham Worldwide, tells Jim Cramer his company is working to get new owners into the time-share market.
Jim Cramer takes a close look at these high-flyers, from Apple to Visa, and asks, "Are they worth it?"
Jim Cramer is bullish on Expedia, Baozun, and Scientific Games.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.